Clinisol Injection, Solution
Product Images NDC 0338-0502

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Clinisol (NDC 0338-0502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clinisol Representative Container Label Ndc 0338-0502-03 (Image 01)

Clinisol Representative Container Label Ndc 0338-0502-03 (Image 01)
This is a description of an Amino Acid injection packaged in a 500 mL Pharmacy Bulk Package with Lot EXP 2B6187 and NDC 0338-0502-03. It contains 15% Clinisol Amino Acid with Pharmacy Bulk Package for intravenous administration as directed by a physician. It has a balanced pH level adjusted with glacial acetic acid, and contains essential and non-essential amino acids. The solution is sterile, non-pyrogenic and has an osmolarity of 1367 mOsmol/l. The container is manufactured by Baxter and has a PL 146 plastic label. It's advisable not to use if the solution is not clear or if it has been penetrated for over four hours.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.